Alvotech (NASDAQ: ALVO)’s stock price has gone rise by 3.89 in comparison to its previous close of 9.78, however, the company has experienced a -3.24% decrease in its stock price over the last five trading days. globenewswire.com reported 2025-05-19 that REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 19, 2025) — Alvotech (NASDAQ: ALVO, the “Company”) has entered into agreement with DNB Carnegie Investment Bank AB (publ) (“DNB Carnegie”) regarding liquidity provider services to ensure liquidity in the Company’s Swedish Depository Receipts (“SDRs”), equity share equivalents, trading on Nasdaq Stockholm. The arrangement is in accordance with the framework of Nasdaq Stockholm’s rules on liquidity providers.
Is It Worth Investing in Alvotech (NASDAQ: ALVO) Right Now?
The price-to-earnings ratio for Alvotech (NASDAQ: ALVO) is above average at 30.13x, Company’s 36-month beta value is 0.10.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ALVO is 108.97M, and currently, short sellers hold a 0.93% ratio of that floaft. The average trading volume of ALVO on May 22, 2025 was 160.87K shares.
ALVO’s Market Performance
The stock of Alvotech (ALVO) has seen a -3.24% decrease in the past week, with a 21.53% rise in the past month, and a -13.16% fall in the past quarter. The volatility ratio for the week is 3.69%, and the volatility levels for the past 30 days are at 4.90% for ALVO. The simple moving average for the past 20 days is 11.76% for ALVO’s stock, with a -11.32% simple moving average for the past 200 days.
Analysts’ Opinion of ALVO
Many brokerage firms have already submitted their reports for ALVO stocks, with UBS repeating the rating for ALVO by listing it as a “Buy.” The predicted price for ALVO in the upcoming period, according to UBS is $18 based on the research report published on February 14, 2025 of the current year 2025.
Barclays, on the other hand, stated in their research note that they expect to see ALVO reach a price target of $17, previously predicting the price at $10. The rating they have provided for ALVO stocks is “Overweight” according to the report published on January 29th, 2024.
Citigroup gave a rating of “Neutral” to ALVO, setting the target price at $10 in the report published on October 20th of the previous year.
ALVO Trading at 7.03% from the 50-Day Moving Average
After a stumble in the market that brought ALVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.65% of loss for the given period.
Volatility was left at 4.90%, however, over the last 30 days, the volatility rate increased by 3.69%, as shares surge +21.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.01% lower at present.
During the last 5 trading sessions, ALVO fell by -3.24%, which changed the moving average for the period of 200-days by -11.96% in comparison to the 20-day moving average, which settled at $9.09. In addition, Alvotech saw -23.20% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ALVO
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.61 for the gross margin
The net margin for Alvotech stands at 0.16. The total capital return value is set at 0.13.
Based on Alvotech (ALVO), the company’s capital structure generated 1.33 points at debt to capital in total, while cash flow to debt ratio is standing at -0.12. The debt to equity ratio resting at -4.06. The interest coverage ratio of the stock is 0.55.
Currently, EBITDA for the company is -28.66 million with net debt to EBITDA at 8.56. When we switch over and look at the enterprise to sales, we see a ratio of 7.27. The receivables turnover for the company is 2.56for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.73.
Conclusion
In a nutshell, Alvotech (ALVO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
